Liposomal oncolytic adenovirus as a neoadjuvant therapy for triple-negative breast cancer

Abstract Breast cancer remains one of the leading causes of cancer-related death, with triple-negative breast cancer (TNBC) accounting for 15–20% of cases. TNBC, characterized by the absence of ER, PR, and HER2 protein, is an aggressive form of breast cancer that is unresponsive to hormonal therapie...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jaimin R. Shah, Tao Dong, Abraham T. Phung, Sohini Khan, Omonigho Aisagbonhi, Sarah L. Blair, Michael Bouvet, William C. Trogler, Andrew C. Kummel
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2025-05-01
Цуврал:	Scientific Reports
Нөхцлүүд:	Triple-negative breast cancer Neoadjuvant therapy Oncolytic adenovirus Coxsackievirus and adenovirus receptor Liposomes Metastasis
Онлайн хандалт:	https://doi.org/10.1038/s41598-025-00211-2
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!